Analysis on morbidity and mortality of viral hepatitis in China, 2004-2013
10.3760/cma.j.issn.0254-6450.2015.02.010
- VernacularTitle:中国2004-2013年病毒性肝炎发病与死亡趋势分析
- Author:
Minna ZHANG
1
,
2
;
Yue YUAN
;
Panyong MAO
;
Yingjie ZHUANG
Author Information
1. 100853北京,解放军医学院
2. 解放军第三○二医院肝脏肿瘤诊疗与研究中心
- Keywords:
Viral hepatitis;
Morbidity;
Mortality;
Prevention
- From:
Chinese Journal of Epidemiology
2015;36(2):144-147
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the incidence and death patterns of viral hepatitis in China and provide evidence for the prevention and control of viral hepatitis.Methods The analysis was conducted on the incidence and death data of viral hepatitis published by National Health and Family Planning Commission during 2004-2013.Results The incidences of viral hepatitis in Guizhou,Yunnan,Tibet,Gansu,Qinghai,Ningxia and Xinjiang provinces (autonomous region) were high.The major forms were hepatitis B (80.63/100 000) and hepatitis C (9.68/100 000),accounting for 80.90％ and 9.25％ of the total reported viral hepatitis cases respectively.The incidences of hepatitis A and unidentified hepatitis decreased and the incidence of hepatitis B,C and E increased during this period.During the 10 years,10 008 deaths caused by viral hepatitis were reported (1 001 deaths per year).The reported deaths caused by hepatitis A,hepatitis E and unidentified hepatitis decreased during this period.The reported deaths caused by hepatitis B were in a downward trend,but the constituent in total cases remained high.The reported deaths caused by hepatitis C were in an upward trend.Conclusion During 2004-2013,the overall incidence of viral hepatitis showed no downward trend in China.The incidence of hepatitis B remained high,and the incidence of hepatitis C showed an obvious upward trend.The overall death rate and case fatality rate of viral hepatitis showed a downward trend,but hepatitis B remained the main cause of viral hepatitis related death,and the death caused by hepatitis C was in increase.Hepatitis B and hepatitis C are the major targets in the prevention and treatment of viral hepatitis in China,and the 7 western provinces (autonomous region) with high incidences are the key regions of the prevention and control.
